West Lafayette medical student Briana Rayman leads the opening of the new Crossroads Student Outreach Clinic at IU Health Arnett Hospital. Rayman is recipient of the Excellence in Action award for her campus.
Bleeding out is the most common cause of preventable death after injury. We are participating in an international study to see if a blood clotting drug, given soon after arrival in the emergency department, can improve survival.
For nearly a decade, lecanemab has been tested in clinical trials at IU School of Medicine. The drug targets the removal of amyloid plaques in the brain—a hallmark of Alzheimer’s disease. Over the past few months, nearly a dozen patients have received the treatment, which is administered through intravenous infusions every two weeks at the IU Health Neuroscience Center in downtown Indianapolis.
Over the last 30 years, Mark R. Kelley has disclosed 61 inventions, been awarded 19 patents and launched a pharmaceutical startup. Now he's helping other IU innovators navigate commercialization for their lab discoveries.
Christina Griffiths is a media relations specialist for Indiana University School of Medicine and has worked with the office of strategic communications for five years. She wrote the following story about her experience learning she is at a high risk of developing breast cancer during her lifetime, and the increased screenings that began as a result.
A pair of investigators from Indiana University School of Medicine recently received prestigious awards from the American Society for Bone and Mineral Research (ASBMR), recognizing their achievements and advancements in the field of bone disease research.